How to Program Cancer Cells
Article Sep 07, 2016
Normal fibroblasts (NFs) are reprogrammed into cancer-associated fibroblasts (CAFs) by miRNA-mediated regulation of FOXO3a/VEGF/CCL2 signalling in lung cancer. CAFs provide oncogenic signals to facilitate tumour initiation, progression and metastasis, and a study, conducted out of First Affiliated Hospital of Nanjing Medical University and Shanghai Jiao Tong University, China, has determined the factors and genes that mediate the conversion of NFs into CAFs, demonstrated this transformation in lung cancer cell studies and carried out some early testing of these factors as anti-cancer therapies.
Published last month in PLOS Genetics, the study initially characterised 3 miRNAs (miR-1, miR-206 and miR-31) that were specifically up- and down-regulated in lung CAFs compared to matched NFs. The team then demonstrated that manipulation of the miRNA levels modulated functional conversion of NFs to CAFs and vice versa. Using a combination of cytokine expression profiling and miRNA algorithms, VEGFA, CCL2 and FOXO3 were identified as direct targets of miR-1, miR-206 and miR-31, respectively. This knowledge, that miRNAs can be manipulated to control cancer cell transformation and identification of their gene targets, provides novel biomarkers and therapeutic targets for lung cancer. Finally, systemic delivery of anti-VEGFA/CCL2 or pre-miR-1, pre-miR-206 and anti-miR-31 was shown to significantly inhibit tumour angiogenesis, TAMs accumulation, tumour growth and lung metastasis. The results provide exciting evidence that such strategies are promising for treatment of lung cancer in the future.
The Glycome and CancerArticle
The surfaces of cancer cells frequently express different types of glycoproteins, and because healthy cells don’t express these molecules (or do so at a much lower level), there has been significant interest in them as potential anticancer targets. Recent advances suggest we are about to see a resurgence in cancer glycomics.READ MORE
Cisplatin Efficacy: The Importance of Measuring Uptake in Cancer CellsArticle
Although cisplatin is clinically proven to combat numerous human cancers – bladder, head and neck, lung, ovarian, testicular – resistance to treatment remains a key challenge, and cisplatin patients can often relapse. Having the ability to determine the cellular uptake of cisplatin is key to developing novel strategies to increase tumor cell sensitivity to cisplatin.READ MORE
The Gene Factory: Can Enzymes Revolutionize Man-Made DNA Synthesis?Article
Building artificial DNA sounds like a technology out of science fiction, but has been conducted in labs for nearly 40 years. To make the potential of synthetic DNA a reality, new methods are being developed that aim to make creating DNA as fast as sequencing it.READ MORE